Cancer Drug Resistance
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Home Articles Special Issues Volumes Webinars Videos

Volume

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Concomitant medications and circulating tumor cells: friends or foes?

New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers

The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates

Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities

Nano-TRAIL: a promising path to cancer therapy

Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment

Targeting regulated cell death pathways in acute myeloid leukemia

Anti-BCMA novel therapies for multiple myeloma

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties